Heroin Addiction and Related Clinical Problems: 2014, 16, 1 (pages: 5 - 8)

Addiction as an extended form of brain disease: heroin-free clinical pictures in the history of addiction. Towards the concept of masked heroin addiction

Maremmani I., and Pacini M.

Heroin Addiction and Related Clinical Problems: 2014, 16, 1 (pages: 9 - 16)

Effect of Methadone Maintenance Therapy (MMT) on serum leptin and lipid profile and anthropometric parameters in opioid addicts

Montazerifar F., Karajibani M., Lashkaripour K., and Yosefi M.

Heroin Addiction and Related Clinical Problems: 2014, 16, 1 (pages: 17 - 24)

Heroin maintenance treatment and immunity: a 12 months follow-up study

Broers B., Roux-Lombard P., Becciolini-Lebas E., Curchod-Fernandez C., and Mino A.

Heroin Addiction and Related Clinical Problems: 2014, 16, 1 (pages: 25 - 34)

Illicit use and diversion of buprenorphine/naloxone among patients in buprenorphine/naloxone maintenance treatment in Istanbul/Turkey

Evren C., Bozkurt M., Cetin T., and Evren B.

Heroin Addiction and Related Clinical Problems: 2014, 16, 1 (pages: 35 - 40)

Requests for quetiapine from jailed substance abusers: are they a form of abuse or self-medication in response to long-term opioid dysphoria?

Pacini M., Santucci B., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2014, 16, 1 (pages: 41 - 44)

Prevalence of HCV infection and adherence to DOT therapy in Italian and non-Italian iv drug users in Rome, Italy

Nosotti L., Fagetti R., Rocchi L., Khoperia M., Mirisola M.C., Testa R., and Leonardi C.

Heroin Addiction and Related Clinical Problems: 2014, 16, 1 (pages: 45 - 48)

How to treat the treatment system

Reisinger M.

Heroin Addiction and Related Clinical Problems: 2014, 16, 1 (pages: 49 - 54)

Does a buprenorphine augmentation control manic symptoms in bipolar disorder with a past history of heroin addiction? A case report.

Bizzarri J., V., Conca A., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2014, 16, 1 (pages: 55 - 62)

Case note review – Transfer of patient to buprenorphine from daily doses of methadone greater than 30mg.

Hill D., and Conroy S.

Heroin Addiction and Related Clinical Problems: 2014, 16, 1 (pages: 63 - 64)

Can the buprenorphine-naloxone association outperform buprenorphine alone?

de Bernardis E., and Busà L.

Heroin Addiction and Related Clinical Problems: 2014, 16, 1 (pages: 65 - 68)

The probable impact of the global financial and economic crisis on medical addiction treatment

Lovrecic M., and Lovrecic B.

Heroin Addiction and Related Clinical Problems: 2014, 16, 2 (pages: 5 - 10)

Breastfeeding may protect against heroin addiction

Akpinar A., Yalniz H., Gecici O., and Guven M.

Heroin Addiction and Related Clinical Problems: 2014, 16, 2 (pages: 11 - 16)

Defining a new approach to measuring outcomes in opioid dependence management:

Alho H., Littlewood R., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2014, 16, 2 (pages: 17 - 22)

A survey of patients on methadone programmes in Wheatfield Prison, Dublin, Ireland.

Galander T., Rosalim J., Betts-Symonds G., and Scully M.

Heroin Addiction and Related Clinical Problems: 2014, 16, 2 (pages: 23 - 30)

Benzodiazepine use in a Methadone Maintained Opiate Dependent Cohort in Ireland

Gilroy D., O'Brien S., Barry J., Ivers J.-H., Whiston L., Keenan E., and Darker C.

Heroin Addiction and Related Clinical Problems: 2014, 16, 2 (pages: 31 - 36)

Buprenorphine/ Buprenorphine-naloxone treatment in opioid dependence and risk of peripheral oedema: Mini-review

Soyka M.

Heroin Addiction and Related Clinical Problems: 2014, 16, 2 (pages: 37 - 42)

Alcohol use disorder and past heroin addiction. A successfully treated ‘masked heroinism' patient

Maremmani A.G.I., Quaranta G., Bacciardi S., Rovai L., Rugani F., Pacini M., Nisita C., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2014, 16, 2 (pages: 43 - 46)

American Association for the Treatment of Opioid Dependence (AATOD) Guidelines for Guest Medication

Parrino M.

Heroin Addiction and Related Clinical Problems: 2014, 16, 2 (pages: 47 - 52)

Case report: Pregnancy and birth under Heroin-assisted Treatment (HAT)

Groh A., Urlichs F., Hillemacher T., Bleich S., and Heberlein A.

Heroin Addiction and Related Clinical Problems: 2014, 16, 2 (pages: 53 - 56)

Drug dreams as a signal of drug craving persistence in time

Colace C.

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 5 - 6)

Preventing opioid overdoses: is the first still the best? should we go back to the origins?

Maremmani I., and Maremmani A.G.I.

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 7 - 14)

Substance abuse in Romania. A clinical medical-legal perspective

Dermengiu D., Sorin H., Radu D., Aciu F., Astarastoae V., Ioan B., Constantinescu G., Enache A., Ciocan V., Talos I., Gorun G., and Curca G.C.

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 15 - 34)

The role of opioid system in Eating Disorders. Perspectives for new treatment strategies.

Rovai L., Maremmani A.G.I., Bacciardi S., Rugani F., Massimetti E., Gazzarrini D., Pacini M., Dell'Osso L., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 35 - 40)

Comparing emotional clarity, emotion experience, and emotion regulation in persons with heroin addiction with and without physical withdrawal

Xin Z., Lu X., Li F., Renlai Z., Ge J., Ling Y., and Yueyue C.

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 41 - 48)

Why do heroin users refuse to participate in a heroin-assisted treatment trial?

Demaret I., Litran G., Magoga C., Deblire C., Dupont A., De Roubaix J., Lemaître A., and Ansseau M.

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 49 - 54)

Sexual dysfunction in male patients receiving methadone and buprenorphine maintenance treatment in Iran

Tafreshian S., Javadi M., Fakhraei F., and Seddigheh Fatemi S.

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 55 - 64)

Outcomes of clonazepam maintained benzodiazepine-heroin addicted patients during methadone maintenance: A descriptive case series

Maremmani A.G.I., Bacciardi S., Rugani F., Rovai L., Massimetti E., Gazzarrini D., Dell'Osso L., Pani P.P., Pacini M., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 65 - 74)

Gender differences in severity of addiction in opiate-dependent outpatients.

Mezzatesta-Gava M., Roncero C., Rodriguez-Cintas L., Fuste G., Barral-Picado C., Martinez-Luna N., Casas M., and Miquel L.

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 75 - 86)

Limbic system irritability and drug dreams in heroin-addicted patients

Colace C., Belsanti S., and Antermite A.

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 87 - 98)

Induction and Switch to Buprenorphine-Naloxone in opioid dependence treatment: Predictive Value of the First Four Weeks

Apelt S.M., Scherbaum N., and Soyka M.

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 99 - 100)

Using oral or i/m morphine for rapid tolerance assessment in patients starting methadone maintenance: a proposal for discussion based on over 25 years of experience

Brewer C.

Heroin Addiction and Related Clinical Problems: 2014, 16, 3 (pages: 101 - 104)

30 Years of Naloxone. The Experience of Villa Maraini Foundation

Barra M., and Lelli V.

Heroin Addiction and Related Clinical Problems: 2014, 16, 4 (pages: 5 - 14)

Evaluation of the Quality of Life in 171 patients under Methadone Maintenance Treatment and in 46 benzodiazepine mono-dependent patients.

Lugoboni F., Carli S., Bissoli G., Musi G., Florio E., Civitelli G., Brizio M., Smacchia C., Biasin C., Cifelli G., Manzato G., Rosa S., and Manzato E.

Heroin Addiction and Related Clinical Problems: 2014, 16, 4 (pages: 15 - 24)

Is it possible to treat heroin addicts with severe comorbid benzodiazepines addiction combining enhanced methadone maintenance and clonazepam maintenance treatments?

Maremmani A.G.I., Bacciardi S., Rugani F., Rovai L., Massimetti E., Gazzarrini D., Dell'Osso L., Pani P.P., Pacini M., and Maremmani I.

Heroin Addiction and Related Clinical Problems: 2014, 16, 4 (pages: 25 - 32)

Health-related quality of life of patients on opiate replacement therapy

McLaughlin J., Surah S., Synnott C., Adams R., Walsh C., O'Dea S., Noone S., Keenan E., Keating S., Barry M., Bergin C., Mulcahy F., and Lyons F.

Heroin Addiction and Related Clinical Problems: 2014, 16, 4 (pages: 33 - 40)

Meeting Report: Guidelines in the treatment of opiate addiction, a review and recommendations

Alho H., Fischer G., Torrens M., Maremmani I., Ali R., and Clark N.

Heroin Addiction and Related Clinical Problems: 2014, 16, 4 (pages: 41 - 48)

Dietary intakes of opiate abusers before and during Methadone Maintenance Treatment

Montazerifar F., Karajibani M., Lashkaripour K., Dorzadeh H., yosefi M., and Dashipour A.-R.

Heroin Addiction and Related Clinical Problems: 2014, 16, 4 (pages: 49 - 54)

Motor impulsivity discriminated relapsed male heroin dependents from those who were still in buprenorphine maintenance treatment at the 12-month follow-up

Evren C., Yilmaz A., Bozkurt M., Can Y., Umut G., and Evren B.

Heroin Addiction and Related Clinical Problems: 2014, 16, 4 (pages: 57 - 62)

Evaluation and cost analysis in two groups of patients who had been randomized for toxicological monitoring

Stella L., Guida F., Nava E., Romano A., Pisanti F., Aprea E., Scala G., Crinisio A., Alfieri A., Coppola O., Leone A., and de Novellis V.

Heroin Addiction and Related Clinical Problems: 2014, 16, 4 (pages: 63 - 70)

Deleterious effects of benzodiazepine abuse among Methadone Maintenance Treatment patients

Peles E., Schreiber S., and Adelson M.

Heroin Addiction and Related Clinical Problems: 2014, 16, 4 (pages: 71 - 78)

Increasing importance of measuring outcomes in opioid dependence care: what matters now and in the future?

Maremmani I., Hill D., Gilman M., and Littlewood R.